BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25226075)

  • 1. Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax.
    Kammanadiminti S; Patnaikuni RK; Comer J; Meister G; Sinclair C; Kodihalli S
    PLoS One; 2014; 9(9):e106393. PubMed ID: 25226075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.
    Mytle N; Hopkins RJ; Malkevich NV; Basu S; Meister GT; Sanford DC; Comer JE; Van Zandt KE; Al-Ibrahim M; Kramer WG; Howard C; Daczkowski N; Chakrabarti AC; Ionin B; Nabors GS; Skiadopoulos MH
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5684-92. PubMed ID: 23979731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen.
    Henning LN; Carpenter S; Stark GV; Serbina NV
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.
    Yee SB; Hatkin JM; Dyer DN; Orr SA; Pitt ML
    Comp Med; 2010 Dec; 60(6):461-8. PubMed ID: 21262133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.
    Leffel EK; Bourdage JS; Williamson ED; Duchars M; Fuerst TR; Fusco PC
    Clin Vaccine Immunol; 2012 Aug; 19(8):1158-64. PubMed ID: 22695155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal-to-Human Dose Translation of ANTHRASIL for Treatment of Inhalational Anthrax in Healthy Adults, Obese Adults, and Pediatric Subjects.
    Beliveau M; Rubets I; Bojan D; Hall C; Toth D; Kodihalli S; Kammanadiminti S
    Clin Pharmacol Ther; 2024 Feb; 115(2):248-255. PubMed ID: 38082506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anthrax immune globulin on response to BioThrax (anthrax vaccine adsorbed) in New Zealand white rabbits.
    Malkevich NV; Basu S; Rudge TL; Clement KH; Chakrabarti AC; Aimes RT; Nabors GS; Skiadopoulos MH; Ionin B
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5693-6. PubMed ID: 23979740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits.
    Corey A; Migone TS; Bolmer S; Fiscella M; Ward C; Chen C; Meister G
    Toxins (Basel); 2013 Jan; 5(1):120-38. PubMed ID: 23344456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax.
    Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; Gonzales N; O'Connor E; Casey LS; Serbina NV
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5796-805. PubMed ID: 27431219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax.
    Migone TS; Bolmer S; Zhong J; Corey A; Vasconcelos D; Buccellato M; Meister G
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1145-51. PubMed ID: 25487792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, Minnesota, USA.
    Sprenkle MD; Griffith J; Marinelli W; Boyer AE; Quinn CP; Pesik NT; Hoffmaster A; Keenan J; Juni BA; Blaney DD
    Emerg Infect Dis; 2014 Feb; 20(2):310-4. PubMed ID: 24447456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax.
    Tournier JN; Rougeaux C; Biot FV; Goossens PL
    mSphere; 2019 Jun; 4(3):. PubMed ID: 31217301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With Ciprofloxacin.
    Vietri NJ; Tobery SA; Chabot DJ; Ingavale S; Somerville BC; Miller JA; Schellhase CW; Twenhafel NA; Fetterer DP; Cote CK; Klimko CP; Boyer AE; Woolfitt AR; Barr JR; Wright ME; Friedlander AM
    J Infect Dis; 2021 Feb; 223(2):319-325. PubMed ID: 32697310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Drabek L; Gooldy M; Heine HS; Henning LN; Lin W; Newman JV; Nevarez R; Siefkas-Patterson K; Radcliff AK; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity.
    Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; O'Connor E; Gonzales N; Mondick J; French J; Stark GV; Fisher AC; Casey LS; Serbina NV
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5787-95. PubMed ID: 27431222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ANTHRASIL (Anthrax Immune Globulin Intravenous (Human)) in rabbit and nonhuman primate models of inhalational anthrax: Data supporting approval under animal rule.
    Kammanadiminti S; Comer J; Meister G; Carnelley T; Toth D; Kodihalli S
    PLoS One; 2023; 18(3):e0283164. PubMed ID: 36930692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax.
    Biron B; Beck K; Dyer D; Mattix M; Twenhafel N; Nalca A
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2206-14. PubMed ID: 25645849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of the Efficacy of FDA-Approved
    Couse Z; Cui X; Li Y; Moayeri M; Leppla S; Eichacker PQ
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33450877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
    Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L
    Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
    Weiss S; Altboum Z; Glinert I; Schlomovitz J; Sittner A; Bar-David E; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7497-503. PubMed ID: 26392505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.